Traumatic right atrial rupture bridge to definitive repair with extra-corporeal life support.

Cardiac injury secondary to non-penetrating trauma is more common than thought, albeit, the injury is usually minor and goes undiagnosed without significant sequelae in most cases. Blunt cardiac rupture is much rarer accounting for <0.05% of all trauma cases but lethal in most circumstances. We present a case report of a young trauma victim who presented with both right atrial rupture and traumatic atrial septal disruption (ASD) requiring extra-corporeal life support (ECLS) and surgical repair. Blunt cardiac trauma with chamber rupture and septal disruption is a devastating injury. Stopping the hemorrhage and using ECLS gave our patient time to stabilize before definitive management of her traumatic ASD.

Long-term performance of the St. Jude Medical valve: low incidence of thromboembolism and hemorrhagic complications with modest doses of warfarin.

Between January 1980 and April 1986, 204 patients were hospital survivors after aortic, mitral, or double valve replacement with the St. Jude Medical valve. One hundred ninety patients underwent anticoagulation with modest doses of warfarin (Coumadin), with prothrombin times in the range of 1.3 to 1.5 times control. Fourteen patients received aspirin and dipyridamole only. Follow-up ranged from 0.5 to 6.6 years (mean 3.1) and was 99.5% complete. The group was analyzed for occurrence of thromboembolism, hemorrhage, valve thrombosis, endocarditis, perivalvular leak, valve failure, late cardiac death, and all morbidity and mortality combined in linear and actuarial terms over the 7 year period. With this anticoagulation regimen, the linear rate for thromboembolism and hemorrhage was 0.67% and 1.3% patient-year, respectively, and the actuarial event-free incidence at 5 years was 97.4% and 94.4%, respectively. There were no instances of structural valve failure and one instance of valve thrombosis in the mitral position. Eighty-seven percent of patients were alive at 5 years and 76.7% of patients were alive and free of all complications at 5 years. We conclude that the St. Jude Medical valve has a low incidence of thromboembolism, hemorrhagic complications, and valve thrombosis in patients receiving modest doses of warfarin.

Biological versus mechanical valves. Analysis of 1,116 valves inserted in 1,012 adult patients with a 4,818 patient-year and a 5,327 valve-year follow-up.

All surviving patients between 18 and 88 years of age receiving biological or mechanical prosthetic heart valves at the Yale-New Haven Hospital from January 1974 through January 1985 were analyzed for thromboembolism, anticoagulation-related hemorrhage, endocarditis, perivalvular leak, valve failure, need for reoperation, late cardiac death, and valve-related death. The rates of these events were analyzed in linear and actuarial terms over the 11 year period. A total of 533 patients received 606 biological valves (328 aortic, 252 mitral, 24 tricuspid, and two pulmonary, consisting of 482 Carpentier-Edwards, 108 Hancock, 15 Ionescu-Shiley, and one other), with a mean follow-up of 2,571 patient-years and 2,935 valve-years. They were compared with 479 patients with 510 mechanical valves (330 aortic, 175 mitral, and five tricuspid, consisting of 178 Starr-Edwards, 166 St. Jude Medical, 164 Björk-Shiley, and two others), which were implanted for 2,247 patient-years and 2,392 valve-years. We found a significantly increased incidence of thromboembolism (p less than 0.001) and reoperation for perivalvular leak (p less than 0.05) in the mechanical valves compared with the biological valves, but a significantly increased rate of valve failure (p less than 0.001) in the biological valves compared with the mechanical valves. The overall analysis comparing total morbidity and valve-related mortality significantly (p less than 0.01) favored the biological valves in the first 5 years of the study and the mechanical valves (p less than 0.001) in the second 5 years of the study. However, the net 10 year results showed no significant difference between the two types of valves. In summary, we found little direct evidence to strongly support the generalized use of one type of valve over another.

Safe technique for aortic anastomosis in orthotopic canine cardiac transplantation.

In canine orthotopic transplantation, bleeding from the aortic suture line is often encountered, leading to the failure of the experiment. A new method for canine aortic anastomosis is described that is safe, simple to perform, and reproducible.

Predictors of outcome in early revascularization after acute myocardial infarction.

We have reviewed 44 consecutive patients undergoing myocardial revascularization from 1 to 42 days after myocardial infarction. Operation within 12 days of transmural myocardial infarction carried a substantially high risk, particularly in patients with poor ventricular function. Patients with subendocardial infarction may be safely operated on shortly after infarction has occurred. In those with transmural infarcts, it may be advantageous to delay operation if early and aggressive medical therapy can effectively control the symptoms. This has to be counterbalanced, however, by the realization that the situation should not be allowed to slide into one of irreparable ventricular damage from infarct extension.

Measurement of central somatosensory conduction time in patients undergoing cardiopulmonary bypass: an index of neurologic function.

It is feasible to monitor somatosensory evoked potentials and central somatosensory conduction times during open heart surgery and cardiopulmonary bypass with moderate or profound hypothermia. Central conduction times are reproducible, have acceptably low interpatient and intrapatient variability, and are not significantly affected by fentanyl-induced anesthesia. There is a predictable logarithmic relationship between central conduction times and temperature with the central conduction time increasing by 6.6 percent for a 1 degree C decrease in temperature. These data indicate that somatosensory conduction times may be a useful index of central nervous system integrity during open heart surgery that utilizes cardiopulmonary bypass and hypothermia.

Noncardiogenic pulmonary edema after cardiopulmonary bypass. An anaphylactic reaction to fresh frozen plasma.

Nine episodes of fulminant noncardiogenic pulmonary edema after cardiopulmonary bypass were observed in eight patients between September 1977 and December 1982. All these catastrophic reactions occurred during administration of fresh frozen plasma 30 minutes to 6 hours after discontinuation of cardiopulmonary bypass. In one patient, two episodes of noncardiogenic pulmonary edema occurred 4 hours apart. In each instance, fresh frozen plasma was being administered. In all patients, pulmonary artery diastolic pressure became elevated during the administration of fresh frozen plasma while left atrial pressure or pulmonary capillary wedge pressure progressively decreased, and cardiac output deteriorated markedly in all but one patient. Corticosteroids, positive end-expiratory pressure, and catecholamines were administered to all patients. All deaths were due to a decrease in cardiac output. Cardiac output did not increase substantially with the use of an intraaortic balloon pump or the administration of catecholamines. The last two patients in the series showed a steady and remarkable improvement in cardiac output when the wedge pressure was increased to a level above 15 mm Hg with the administration of normal saline solution. Our data suggest the following: (1) noncardiogenic pulmonary edema after cardiopulmonary bypass is most probably an anaphylactic reaction to fresh frozen plasma. (2) The syndrome is reversible within hours; in only one patient (who suffered noncardiogenic pulmonary edema twice) did adult respiratory distress syndrome develop. (3) The three deaths were not related to hypoxia but to the deleterious effects of low cardiac output associated with hypovolemia secondary to fluid loss through the lungs and possibly across other capillary beds. Therefore, treatment should include restoration of adequate left-sided filling pressures to achieve satisfactory cardiac output.

Combined valve replacement and myocardial revascularization.

Combining valve replacement with coronary artery bypass (CABG) for significant concomitant disease remains a controversial subject. To determine the operative results following combined valve replacement and CABG, we evaluated 201 patients seen consecutively between July 1977 and June 1982. CABG for vessels with greater than 70% stenosis was performed with aortic valve replacement in 106 patients, with mitral valve replacement in 82, and with aortic and mitral valve replacement in 13. There were 143 men and 58 women; the mean age was 67 years. Nine operative deaths (8.5%) occurred with aortic valve replacement and CABG: 5 of 25 (20%) when cardioplegia was not used and 4 of 81 (4.9%) with cardioplegia (p less than 0.01). The operative mortality rate for isolated aortic valve replacement without coronary disease during the same period was 5.9% (10 of 168). The late actuarial survival rate is similar for aortic valve replacement alone or aortic valve replacement and CABG. There were no operative deaths among patients having undergone aortic and mitral valve replacement and CABG; the rate was 15% (9 of 60) in patients having undergone aortic and mitral replacement and CABG. The operative mortality rate was 21.9% for mitral valve replacement and CABG (18 of 82). Rheumatic disease was present in 14 of these patients, two of whom had early deaths (14.3%), both after repeat mitral operations; 11 mitral valve replacements and CABG were done for degenerative mitral regurgitation with no deaths, and the remaining 57 patients had ischemic mitral regurgitation.(ABSTRACT TRUNCATED AT 250 WORDS)

Optimal methods of repair of descending thoracic aortic transection and aneurysms.

The method for optimal protection of the spinal cord and viscera during surgical repair of aneurysms and acute disruptions of the descending thoracic aorta is controversial. We reviewed our experience with 50 consecutive patients who underwent such repairs between January 1968 and April 1982 to determine the safest method of protection. Thirty-two had acute transections, 9 had ruptured aneurysms, 6 had false aneurysms, and three had atherosclerotic aneurysms. Extracorporeal circulation was used in 21 patients with an average cross-clamp time of 67 minutes, a Gott shunt was used in 26 with an average cross-clamp time of 74 minutes, and no shunt was used in 3 patients with cross-clamp times of 20, 24, and 50 minutes. Paraplegia was significantly reduced with both extracorporeal circulation and the heparin-bonded Gott shunt; however, the former method was associated with a high incidence of postoperative bleeding in conjunction with systemic heparinization, and this, in turn, contributed to a high mortality, particularly in patients with traumatic transection who often had associated severe injuries. We believe that the Gott shunt provides the best protection, particularly in the setting of a training program where a relatively small number of these operations are performed and cross-clamp times may be prolonged.

The role of mediastinoscopy and mediastinotomy in lung cancer.

Mediastinoscopy and mediastinotomy have a major role in patients with bronchogenic carcinoma. In some instances, they lead to a histologic diagnosis of a tumor of unknown cell type seen by chest roentgenogram, when other diagnostic methods have failed to do so. By far the most important role of these procedures is to stage the mediastinum for better selection of patients for surgery. Thoracotomy has a low morbidity and mortality; nevertheless, it is a formidable operation. If thoracotomy is used indiscriminately in patients with bronchogenic carcinoma who are referred for surgical treatment, many of these patients "lose, just through the operation, one or two of the best months they have left to live." In the five categories of patients described, mediastinoscopy and mediastinotomy are the most effective and economic methods for predicting who will benefit from thoracotomy and resection.